retatrutide phase 2 trial results obesity New 3 data just dropped 👀 Eli Lilly's reported average retatrutide phase 2 trial results

When she was on Wegovy, she said, her A1C glucose levels started to rise close to prediabetic levels despite consistent diet and exercise habits

Its not worth the few dollars you might save to put your health at risk

2021;70(Suppl 1)

Metabolic Risk (Lower): Due to its very short half-life (approximately 20 minutes), IGF-1 DES poses a lower risk of sustained, systemic hypoglycemia compared to the long-acting IGF-1 LR3

And, I mean, I think we're going to see, I hope we're going to see, a lot more functional MRI type studies where people say, "Yeah, yeah, yeah

PlexusDx is not affiliated with Ro and has no commercial relationship with the companies reviewed